Question 1

Does Two Sigma Advisers own CYTK stock?

Accepted Answer

Yes. As of its Q4 2025 13F, Two Sigma Advisers holds 174,700 shares of CYTK (Cytokinetics), worth $11.1M.

Question 2

How many shares of CYTK does Two Sigma Advisers own?

Accepted Answer

As of its Q4 2025 13F, Two Sigma Advisers holds 174,700 shares of CYTK (Cytokinetics).

Question 3

What is Two Sigma Advisers' CYTK position worth?

Accepted Answer

As of its Q4 2025 13F, Two Sigma Advisers' CYTK position is worth $11.1M.

Question 4

Is Two Sigma Advisers buying or selling CYTK?

Accepted Answer

In Q4 2025, Two Sigma Advisers opened a new CYTK position of 174,700 shares.

Question 5

When did Two Sigma Advisers first buy CYTK?

Accepted Answer

Two Sigma Advisers already held CYTK in its Q4 2018 13F, the earliest on record, and has listed it in 26 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	New	174,700	—	$11.1M	0.0%	$63.54	38
2025-Q2	Exited	0	-100.0%	$0	0.0%	$33.04	0
2025-Q1	Decreased	80,400	-64.5%	$3.2M	0.0%	$40.19	0
2024-Q4	Increased	226,400	+5.5%	$10.6M	0.0%	$47.04	29
2024-Q3	New	214,700	—	$11.3M	0.0%	$52.80	39